Please login to the form below
grant funding
This page shows the latest grant funding news and features for those working in and with pharma, biotech and healthcare.
Latest news
-
UK biotech funding falls 40% between 2018 and 2019
Despite funding falling down in the UK in 2019, the BIA noted that this drop in biotech investment was replicated in most regions across the globe. ... Government efforts to leverage new scale-up capital through the British Business Bank and the UK
-
£1 billion cuts to public health must be reversed, say charities
The sustained cuts to the public health grant clearly run counter to these aims. ... The government’s Spending Review was expected to outline long-term funding for the public health grant, but the review looks certain to be delayed amid Brexit-induced
-
European Research Council readies €2bn in science funding
In addition, the council is also re-introducing the ‘much anticipated’ synergy grants, a funding scheme for groups of two to four scientists who jointly address ‘ambitious’ research problems. ... By providing 250m of funding for the Synergy Grant
-
Grünenthal research consortium receives €1.5m EU grant
A research consortium that aims to improve the development of new analgesic drugs has been awarded a 1.5m grant from the EU's regional development fund and the Federal State ... The EU funding will support research into the molecular foundations of
-
Biomedical Catalyst funding 'must continue', says BIA
Moreover, another £1bn-plus has subsequently been raised by BMC-funded companies and academics "in the form of additional private finance, grant funding, via licencing or acquisition.". ... this early-stage funding could threaten the UK's
UK biotech funding falls 40% between 2018 and 2019
£1 billion cuts to public health must be reversed, say charities
European Research Council readies €2bn in science funding
Grünenthal research consortium receives €1.5m EU grant
Biomedical Catalyst funding 'must continue', says BIA
More from news
Approximately 0 fully matching, plus 13 partially matching documents found.
Latest Intelligence
-
Keeping up the fight against HIV and using the lessons to tackle other threats
Gilead is funding eight to ten global projects under the NASH Models of Care Program that aims to develop multi-disciplinary pathways to screening, identifying and treating high-risk NASH patients. ... Patient feedback. Gilead’s HIV Age Positively
-
Deal Watch June 2016
The EU has been a significant source of grant funding for the life science sector through initiatives such as the Framework programmes and Horizon 2020. ... The agreement could result in a total of up to $169m in funding over ten years.
-
Pharma deals during March 2013
deals usually include ongoing R&D funding, they tend to be back-loaded. . ... Grant funding. To manufacture and bank stem cell lines (platform). 26.
Keeping up the fight against HIV and using the lessons to tackle other threats
Deal Watch June 2016
Pharma deals during March 2013
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
Virtual Research Grants Submission and Approval Program
Set up an online system where clinicians and scientists can submit their research grant proposals. ... Facilitate the review and scoring of the grant proposals. Provide funding for one clinical, pre-clinical, laboratory, or epidemiological research
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Medical Writer, Women’s health, Medical Communications agency, h...
-
Highly competitive salary
-
Senior Account Manager
-
Competitive salary offered
-
Omnichannel Strategy Consultant
-
Competitive Salary
- Results of AstraZeneca’s TACKLE phase 3 trial show antibody combination reduces risk of severe COVID-19 or death
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- Data shows patients treated with Biogen's MS therapies mount an effective antibody response to COVID-19 vaccination
- US demand for COVID-19 antibody treatments rising fast
- Assessing the value of interim analyses in clinical trials
- AstraZeneca chooses Ireland for $360m manufacturing site
- Engaging HCPs on their own terms: how pharma can adapt to the post-pandemic digital era
- Breaking the silence: It’s time to talk about the menopause
- FDA accepts Regeneron’s REGEN-COV for priority review for treatment of COVID-19
- New data shows Roche's Enspryng significantly reduces neuromyelitis optica spectrum disorder relapses
- Beyond yoga and smoothies – providing real support for employee well-being
- Driving Healthcare Decisions with Natural Language Processing
- Results of AstraZeneca’s TACKLE phase 3 trial show antibody combination reduces risk of severe COVID-19 or death
- Novo Nordisk settles US insulin pricing dispute for $100m
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- Onyx Health appoints Dean Forbes
- Sandoz completes acquisition of GSK’s cephalosporin business
- Public is more comfortable with health data sharing if they know it is to support breakthrough treatments and vaccines
PMHub
Videum Health
Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...
Latest intelligence
- Breaking the silence: It’s time to talk about the menopause
- Using findings from our latest opinion poll, Vicki Newlove outlines why the hidden landscape of menopause may finally be starting to change....
- Committing time to making meaningful connections - top 5 tips
- Read the second blog of the series looking at key barriers to effective patient engagement in pharma...
- News:
- Senior Analytics Specialist joins Research Partnership...
